New Israeli Drug Cured 29 of 30 Moderate/Serious COVID Cases in Days
A new coronavirus treatment being developed at Tel Aviv’s Ichilov Medical Center has successfully completed phase 1 trials and appears to have helped numerous moderate-to-serious cases of COVID-19 quickly recover from the disease, the hospital said Friday.
Hailing a “huge breakthrough,” the hospital said Prof. Nadir Arber’s EXO-CD24 substance had been administered to 30 patients whose conditions were moderate or worse, and all 30 recovered — 29 of them within three to five days.
The medicine fights the cytokine storm — a potentially lethal immune overreaction to the coronavirus infection that is believed to be responsible for much of the deaths associated with the disease. (TOI / VFI News)
“God, we ask that you continue to bless us with new medicines and other medical breakthroughs.”
The articles included in this publication do not necessarily reflect the views or opinions of Vision for Israel. We try to provide accurate reporting on news pertinent to Israel, the Middle-East, the diaspora, and Jewish issues around the world—and we hope that you find it both informative and useful for intercessory prayer.